Focus Area: Clinical Trials & Research

A Conference on Post-Trial Responsibilities: Ethics and Implementation

September 18, 2014 @ 7:30 am – 5:30 pm

Harvard Law School, Wasserstein Hall, Millstein East, Cambridge, MA

The objectives of the conference were to discuss implications of international guidance on post-trial responsibilities for clinical research, to articulate and understand the range of perspectives on post-trial responsibilities, to draw lessons from successful and unsuccessful attempts to implement post-trial policies, and to discuss potential scenarios and practical solutions for post-trial responsibilities that may inform policy in this important area moving forward.

For more information please see links below.

2014-09-18–Proceedings – Post Trial Access Conference

2014-09-18–Agenda Post Trial Access Conference

Deliverables

Projects

Declaration of Helsinki comments: Declaration of Helsinki, issued for public comment by the Counsel of the WMA in April 2013

MRCT Center at Harvard responded to the World Medical Association’s request for comments or potential revisions to the Declaration of Helsinki (DoH), which will reach its 50th anniversary in 2014.

To maintain its relevance and prominence as a guidance document for clinical research, revisions are frequently made to the DoH. Revisions for the 50th Anniversary will be published in 2014. Staff, sponsors, and academic affiliates of the MRCT Center collaborated to submit the attached comments to the World Medical Association.

Comments are available here

Comments on Declaration of Helsinki